Latest Aggregates News

Duxton Farms has announced a strategic merger with four private agricultural companies, aiming to significantly expand its asset base and diversify its commodity exposure. The move positions the company for enhanced market presence and long-term growth.

Freehill Mining reported a transitional quarter marked by a dip in sales due to project cycles but offset by strategic site acquisitions and a successful capital raise. The company is poised for growth with new processing sites and promising magnetite test results.

Savannah Goldfields reported a $4.06 million cash outflow in Q2 2025 but is advancing plans to restart gold production and secure additional funding.

Venus Metals Corporation has made significant progress at its Bellchambers Gold Project with the granting of a mining lease and encouraging drilling results, while advancing base metals exploration at Youanmi.

Pacific Current Group reports a 3.1% decline in funds under management in Australian dollars for Q4 FY25, driven largely by currency appreciation despite modest inflows and performance gains in native currencies.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Centuria Capital No. 2 Fund confirms full compliance with note terms and stable loan positions in its Q4 FY25 report, reassuring investors amid a steady operational quarter.

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

VRX Silica Limited has successfully concluded the environmental appeal process for its Arrowsmith North Silica Sand Project, with the WA Minister for Environment confirming the adequacy of the EPA assessment. The company is now advancing financing discussions and offtake agreements as it awaits formal project approval.

Alterity Therapeutics has reported encouraging topline results from its open-label Phase 2 trial of ATH434 in advanced Multiple System Atrophy, showing slowed disease progression and biomarker stabilization.

Anax Metals has raised $3.3 million through convertible notes to push forward its Whim Creek copper-zinc project in Western Australia, while resolving a recent arbitration with its cornerstone investor Mineral Development Partners.

Asra Minerals plans to rename itself GoldArc Resources and consolidate its shares on a 10-for-1 basis, aligning its corporate identity with a focused gold exploration strategy in Western Australia’s Eastern Goldfields.